A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06271538

Title field or adapter rule

{'original_value': 'A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.870655+00:00

Published At

2026-09-11T00:00:00+00:00

Record Updated At

2026-09-11

Source Retrieved At

2026-10-31T22:18:48.933435+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Irritable Bowel Syndrome", "Gastrointestinal Diseases", "Colonic Diseases, Functional", "Intestinal Disease", "Digestive System Disease", "Pathologic Processes", "Colonic Disease", "Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-11", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06271538"

protocolSection.identificationModule.officialTitle

"A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Sk\u00e5l Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Irritable Bowel Syndrome (protocolSection.conditionsModule.conditions)
• Gastrointestinal Diseases (protocolSection.conditionsModule.conditions)
• Colonic Diseases, Functional (protocolSection.conditionsModule.conditions)
• Intestinal Disease (protocolSection.conditionsModule.conditions)
• Digestive System Disease (protocolSection.conditionsModule.conditions)
• Pathologic Processes (protocolSection.conditionsModule.conditions)
• Colonic Disease (protocolSection.conditionsModule.conditions)
• Disease (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Skal Pro'], 'description': 'One sachet Skal Pro per day containing Lactobacillus plantarum 299v 1x10\\^10 CFU and GOS', 'name': 'Skal Pro', 'type': 'COMBINATION_PRODUCT'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo'], 'description': 'One sachet per day identical in shape, size, colour, packaging and taste to the Skal Pro sachet', 'name': 'Placebo', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.